Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Irwin Naturals Inc (OP: IWINF )

2.170 UNCHANGED
Last Price Updated: 10:26 AM EDT, Mar 20, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 2.170
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 2.170
Today's Range 2.170 - 2.170
52wk Range 0.8000 - 3.500
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Irwin Naturals Cannabis Products Launch Nationwide In Canada
Irwin Naturals Inc. (OTCQB: IWINF) (CSE:IWIN) (FRA:97X) announced the release of Irwin Naturals Cannabis’ new CBD 25mg Softgels in Canada, available nationwide through the Starseed Medicinal Medical... 
Via Benzinga
Irwin Naturals Acquires Ketamine Media
Irwin Naturals Inc. (OTCQB: IWINF) (CSE:IWIN) (FRA: 97X) acquired Keta Media, LLC, dba Ketamine Media. 
Via Benzinga

Performance

YTD
-16.54%
-16.54%
1 Month
-21.09%
-21.09%
3 Month
-14.57%
-14.57%
6 Month
+100.89%
+100.89%
1 Year
-31.97%
-31.97%

More News

Read More
Psyched: 22 States With Reform Bills, Ketamine Therapy Services Today, Oscars On Shrooms & More
Via Benzinga
Major Ketamine Clinics Chain Decides Not To Pursue Acquisition Deal
Via Benzinga
In-Clinic Ketamine Businesses Are Shutting Down All Across The US, A Rising Trend?
Via Benzinga
Here Are The Year's Highest Priced Psychedelics Stocks In US Markets
Via Benzinga
Braxia Scientific's Q3 2023 Finances, Update On Upcoming Acquisition With Irwin Naturals
Via Benzinga
Psyched: Hawaii And Minnesota's Bills, Studying 2C-B Vs. Psilocybin, Filament CEO, Plus Brock Pierce And Jeremy Gardner Discuss The Industry's Future And More
Via Benzinga
Psyched: Four New States With Reform Bills, Psilocybin For Genetic Disorders And Functional Neurological Disorder, Struggle For Access & More
Via Benzinga
Irwin Naturals Acquires Ketamine Clinic In Kentucky Adding $3M In Projected EBITDA
Via Benzinga
Psyched: Australia Legalizes Psychedelics Therapy, BC's Decrim, State Bills, Millions For Trials & Clinics
Via Benzinga
'Sea Change': Irwin Naturals, Numinus And Field Trip Discuss Psychedelics At Cantor Webinar
Via Benzinga
Irwin Naturals Secures $40M To Accelerate Expansion Of Its Psychedelic Mental Health Clinics
Via Benzinga
Irwin Naturals Signs LOI To Acquire Braxia Scientific Expanding Its Network Of Mental Health Clinics
Via Benzinga
Irwin Naturals TCH Products To Hit The Shelves Of ~2700 Dispensaries In Oklahoma Via Gold Rush
Via Benzinga
Irwin Naturals, Numinus, Field Trip: Sector Analyst Compares Footprints, Cash, Organic Growth
Via Benzinga
6 Psychedelics Companies Take Action: Here Are The Latest, Major Announcements
Via Benzinga
Irwin Naturals To Enter Oregon Cannabis Market Via Hyphae Wellness
Via Benzinga
Psyched: Psychedelic Therapy In The Workplace, UCL's Brain Imaging Study, COMPASS Trials And More
Via Benzinga
Mental Health Clinic Poised To Become Leader In A Projected $50B Industry, Analyst Says
Via Benzinga
Irwin Naturals Completes The Acquisition Of Three Mental Health Clinics
Via Benzinga
Psyched: Fed Guidelines And Research Production Quotas, Protests In Canada, Cal's Decrim Project
Via Benzinga
Irwin Naturals Q3 Revenue Declines 7% YoY, What About Adjusted EBITDA?
Via Benzinga
Irwin Naturals To Acquire Serenity Health
Via Benzinga
Irwin Naturals THC Products To Be Available In Mississippi Cannabis Dispensaries
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.